GARFIELD-VTE registry

GARFIELD-VTE observed treatment and outcomes in patients with acute venous thromboembolism in the real world

Search for:

Home
- - Explore the tree
    For a summary of our published findings, explore the GARFIELD tree either by clicking on the branches or by using the navigation links below.
    Burden of Disease
    Cancer-Associated Thrombosis
    Treatment Patterns
    Clinical Outcomes
    Patient Reported Outcomes
    Geographic Differences
    Health Economics
Close
About
Publications & Presentations
Newsletters
Media
Community Page

Geographic Differences

GARFIELD-AF has enroled over 57,000 patients from more than 1,000 centres across 35 countries including the Americas, Europe, Africa and Asia-Pacific.

Coming soon…

Key Publications:

Related Publications

Click to view publications related to Geographic Differences... [read more]

16 Jun 21

Community members, please login to view additional information

Global Status

Total patients 10,869

Recruitment Recruitment closed

Follow-up Follow-up ongoing
Study end: 2020

Contact Us

To find out more about GARFIELD-VTE, please contact the Thrombosis Research Institute.

info@tri-london.ac.uk Contact Us

Keep Up to Date

Sign-up to our newsletter to receive news and updates from us

Keep Up to Date

Funding

The GARFIELD-VTE registry was funded by an unrestricted research grant from Bayer AG, and the ongoing work is supported by the Kantor Charitable Foundation for the Kantor-Kakkar Global Centre for Thrombosis Science.